RxDoctor Payments Data

Anne Beauchamp

Psychiatric/Mental Health · Grand Rapids, MINPI 1003672528

Payments from drug & device makers

$2,089in general payments, 2019–2025

Across 156 payments — averaging $13.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$433
  • Supernus Pharmaceuticals, Inc.$345
  • Neurocrine Biosciences, Inc.$310
  • Otsuka America Pharmaceutical, Inc.$255
  • Teva Pharmaceuticals USA, Inc.$216
  • Lundbeck LLC$162
  • plus $367 from 7 others

What the payments were for

  • Food & beverage$2,089100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,089 in reported general payments places this provider in the 75th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan

Medicare billing

Part B allowed, 2024
$11,780
Medicare patients
36
Services billed
110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl11$19,438
TrintellixVortioxetine Hydrobromide13$9,037
Vilazodone Hcl16$2,569
Olanzapine70$1,853
Trazodone Hcl95$1,730
Quetiapine Fumarate73$1,299
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine36$1,106
Methylphenidate Hcl54$1,032
Venlafaxine Hcl ErVenlafaxine Hcl40$972
Hydroxyzine Hcl18$822
Duloxetine Hcl29$743
Gabapentin43$742
Clozapine13$726
Prazosin Hcl30$686
Lamotrigine44$609

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$433$19,43811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →